Stock

UK’s CMA may accept Synopsys/Ansys deal remedies

1 Mins read

Investing.com — The UK’s Competition and Markets Authority (CMA) said it may accept the remedies offered by Synopsys (NASDAQ:SNPS) and Ansys (NASDAQ:ANSS). The agency now has until until March 5, 2025 to make an official decision. The undertakings, offered by both companies at the end of last year on December 31, include the divestment of certain product lines.

Specifically, Ansys has proposed to divest its product for power consumption analysis of digital chips. On the other hand, Synopsys has offered to divest its Optical Solutions Group. The CMA has stated that there are reasonable grounds to believe that these undertakings might be accepted.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com

Related posts
Stock

Barclays bullish on Partners Group, upgrades to ‘overweight’

1 Mins read
Investing.com — Barclays (LON:BARC) has upgraded Partners Group to “overweight,” reflecting increased confidence in its outlook for 2025, in a note dated…
Stock

UK consumer confidence falters after Christmas splurge

2 Mins read
By James Davey, Paul Sandle and Sarah Young LONDON (Reuters) – Shares in Britain’s Marks & Spencer (OTC:MAKSY) and other retailers fell…
Stock

UBS upgrades Shell, Repsol to ‘buy’, downgrades Eni to ‘neutral’

1 Mins read
Shell (LON:SHEL) and Repsol (OTC:REPYY) have been upgraded to “buy” by analysts at UBS Global Research analysts, while Eni has been downgraded…

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.